NIV success (n = 72) | NIV failure (n = 16) | OR (95% CI) | p Value | |
Age, n = 88* | 68 (10) | 77 (9) | 0.9 (0.84 to 0.97) | 0.006 |
Gender, n = 88† | M = 34 | M = 5 | 1.97 (0.62 to 1.97) | 0.25 (NS) |
F = 38 | F = 11 | |||
Smoking status, n = 88† | Ex = 37 | Ex = 10 | 0.57 (0.19 to 1.72) | 0.32 (NS) |
Current = 35 | Current = 6 | |||
FEV1 (litres), n = 82* | 0.69 (0.30) | 0.60 (0.17) | 4.53 (0.19 to 106.4) | 0.35 (NS) |
FVC (litres), n = 82* | 1.67 (0.55) | 1.35 (0.48) | 3.64 (0.73 to 18.07) | 0.11 (NS) |
Diagnosis of diabetes mellitus, n = 16† | 12 | 4 | 0.6 (0.17 to 2.18) | 0.44 (NS) |
Glucose ⩾7 mmol/l, n = 88† | Glucose ⩾7 mmol/l = 29 | Glucose ⩾7 mmol/l = 15 | 0.05 (0.006 to 0.36) | 0.003 |
Glucose <7 mmol/l = 43 | Glucose <7 mmol/l = 1 | |||
Time from admission to NIV administration (h), n = 88* | 4.68 (4.76) | 3.59 (3.85) | 1.07 (0.92 to 1.24) | 0.40 (NS) |
IPAP (cm H2O), n = 88* | 15.07 (2.17) | 15.00 (3.29) | 1.01 (0.80 to 1.28) | 0.34 (NS) |
EPAP (cm H2O), n = 88* | 5.24 (1.38) | 5.63 (1.78) | 0.84 (0.58 to 1.2) | 0.16 (NS) |
APACHE II, n = 88* | 14.63 (3.80) | 19.19 (4.31) | 0.76 (0.65 to 0.89) | 0.001 |
Oral corticosteroid administered prior to admission, n = 16† | 14 (19%) | 2 (13%) | 1.69 (0.34 to 8.31) | 0.52 (NS) |
Charlson comorbidity index, n = 88* | 1.62 (0.73) | 1.88 (0.93) | 0.78 (0.35 to 1.25) | 0.20 (NS) |
GCS, n = 88* | 14 (1) | 13 (3) | 1.21 (0.93 to 1.45) | 0.18 (NS) |
Pneumonia cases, n = 11† | 7 | 4 | 0.32 (0.08 to 1.28) | 0.12 (NS) |
Baseline RR (breaths/min), n = 88* | 26 (6) | 34 (10) | 0.86 (0.79 to 0.94) | 0.001 |
Values are given as mean (SD).
*t test. †χ2 test.
APACHE II, Acute Physiology and Chronic Health Evaluation II; EPAP, expiratory positive airway pressure; F, female; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GCS, Glasgow Coma Score; IPAP, inspiratory positive airway pressure; M, male; NIV, non-invasive ventilation; NS, non-significant; RR, respiratory rate;